StockData
Protagonist Therapeutics, Inc logo

Protagonist Therapeutics, Inc (PTGX) stock

PTGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/30199% above fair value
$124.67−0.16 (-0.13%)

Close on Nov 17, 2026Market cap $8.07BP/E 121.0Yield –

How the market prices Protagonist Therapeutics

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Protagonist Therapeutics trades at 28.6× its earnings, against a median of 16.1× since 2016 — on the expensive side of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2016

Median 16.1×, today 28.6×

What Protagonist Therapeutics keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Operating margin20.7%vs -42.9%
EBITDA margin21.2%vs -29.3%
Pretax margin29.9%vs -13.0%
Net margin29.4%vs -39.9%
Free cash flow margin46.3%vs -9.41%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity11.0%vs -53.5%
Return on assets10.3%vs -40.7%
Return on invested capital73.3%vs -32.4%
Return on capital employed6.88%vs -38.7%

How hard the assets work

Revenue per dollar of assets0.35vs 0.39
Revenue per employee$2.14Mvs $405.05K
Profit per employee$628.10Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $782.58M. That is 10.7% of the $7.29B it would cost to buy the business outright.

Cash and short-term investments$782.58M
EBITDA, trailing twelve months$59.88M
Free cash flow, trailing twelve months$130.58M

Leverage and liquidity

Current ratio21.71vs 3.30
Quick ratio21.05vs 2.38

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

111.24
DistressSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

5 of 9 tests passed

Price against two rules of thumb

Graham's number and Lynch's fair value, both derived from current earnings.

Graham $17.36Price $124.83

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield1.03%vs -22.5%
Free cash flow yield1.62%vs -9.38%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$77.0052-week low52-week high$160.81
200-day$124.8320-day50-day

The close sits 57% of the way up the 52-week range, 22.4% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

33
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

PTGXS&P 500
PeriodPTGXS&P 500DifferencePTGX per yearS&P 500 per year
1 month-3.2%-4.0%+0.9 pts
3 months-21.4%-5.0%−16.4 pts
Year to date+42.7%+8.2%+34.5 pts
1 year+47.1%+11.2%+35.9 pts
3 years+641.6%+68.5%+573.2 pts+95.0%+19.0%
5 years+242.3%+67.3%+175.0 pts+27.9%+10.8%
10 years+398.9%+291.6%+107.2 pts+17.4%+14.6%

How much it moves

Volatility, 1 year40.3%vs 80.4%
Volume against its 90-day average0.89vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

10M PTGX shares were sold short on Oct 30, 2026, down 0.5% from the previous report, or 16.09% of the shares available to trade. At recent volumes it would take 16.9 days to buy them back. Over the last 20 sessions, 60.2% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float16.1%vs 8.91%
Short interest as a share of all shares15.8%vs 6.30%
Days of volume to buy it back16.89vs 5.16

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202610,242,340-0.5%606,26116.9
Oct 15, 202610,297,224+10.2%856,44812.0
Sep 30, 20269,345,382+14.8%813,30011.5
Sep 15, 20268,140,194+5.5%538,02315.1
Aug 31, 20267,712,543-1.0%502,80215.3
Aug 14, 20267,791,795+3.3%474,58116.4
Jul 31, 20267,543,109-9.0%530,73914.2
Jul 15, 20268,292,656+7.8%870,3749.5
Jun 30, 20267,691,347-0.5%1,065,1767.2
Jun 15, 20267,728,416+4.3%666,63611.6
May 29, 20267,410,849+1.6%440,77616.8
May 15, 20267,293,819-3.3%571,83112.8

Every measure, in full

90 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 24, 2027 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 16, 2026

Valuation ratiosIndustry

Market Cap
$8.08B
$261.21M
Enterprise Value
$7.29B
$135.05M
PE Ratio
121.19
23.48
PS Ratio
28.64
3.76
PB Ratio
9.60
2.01
P/TBV Ratio
9.60
2.23
P/FCF Ratio
61.86
18.76
P/OCF Ratio
61.57
13.21

Enterprise valuationIndustry

EV / Sales
25.87
2.44
EV / EBITDA
121.82
16.15
EV / EBIT
125.04
18.75
EV / FCF
55.87
21.73

Share statisticsIndustry

Shares Change (YoY)
5.73%
10.9%
Shares Change (QoQ)
0.69%
0.57%
Float
64M
49M
Shares Held by Insiders
1.65%
11.2%
Shares Held by Institutions
117.1%
56.2%

Short sellingIndustry

Short Interest
10M
–
Short Interest Change
-0.53%
-0.81%
Short % of Float
16.1%
8.91%
Short % of Shares Outstanding
15.8%
6.30%
Days to Cover
16.89
5.16

Stock price statisticsIndustry

52-Week High
$160.81
–
52-Week Low
$77.00
–
20-Day Moving Average
$137.71
–
50-Day Moving Average
$139.88
–
200-Day Moving Average
$119.51
–
Average True Range (14)
$5.99
–
Price Change (1 Week)
-8.15%
-7.62%
Price Change (1 Month)
-3.04%
-4.88%
Price Change (3 Months)
-20.7%
-24.2%
Price Change (6 Months)
23.9%
-21.7%
Price Change (YTD)
42.9%
-26.2%
Price Change (1 Year)
50.0%
-22.5%
Price Change (3 Years)
642.6%
-31.7%
Price Change (5 Years)
242.8%
-77.9%
Price Change (10 Years)
396.7%
-66.0%
Average Volume (10 Days)
634,579
–
Average Volume (20 Days)
603,332
–
Average Volume (90 Days)
627,845
–
Relative Volume
0.89
0.86
Relative Strength Index (14)
32.6
40.8
Volatility (1 Year)
40.3%
80.4%

MarginsIndustry

Operating Margin
20.7%
-42.9%
Pretax Margin
29.9%
-13.0%
Profit Margin
29.4%
-39.9%
EBITDA Margin
21.2%
-29.3%
FCF Margin
46.3%
-9.41%

Returns on capitalIndustry

Return on Equity (ROE)
11.0%
-53.5%
Return on Assets (ROA)
10.3%
-40.7%
Return on Invested Capital (ROIC)
73.3%
-32.4%
Return on Capital Employed (ROCE)
6.88%
-38.7%

Financial positionIndustry

Current Ratio
21.71
3.30
Quick Ratio
21.05
2.38

GrowthIndustry

Revenue Growth (YoY)
34.8%
5.71%
Net Income Growth (YoY)
59.3%
-31.1%
EPS Growth (YoY)
47.1%
-25.8%
FCF Growth (YoY)
252.0%
3.26%
Revenue Growth (3Y CAGR)
20.1%
2.25%
Revenue Growth (5Y CAGR)
9.96%
6.41%

EfficiencyIndustry

Asset Turnover
0.35
0.39
Revenue Per Employee
$2.14M
$405.05K
Profits Per Employee
$628.10K
-$704.12K
Employee Count
132
75

Income statement (TTM)Industry

Revenue
$281.99M
$58.79M
Operating Income
$58.34M
-$21.49M
Pretax Income
$84.34M
-$14.83M
Net Income
$82.91M
-$22.47M
EBITDA
$59.88M
-$17.14M
EPS (Diluted)
$1.03
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$782.58M
$15.35M
Net Cash Per Share
$12.09
$0.71
Equity (Book Value)
$841.54M
$49.84M
Book Value Per Share
$13.01
$1.45
Tangible Book Value
$841.54M
$23.91M
Working Capital
$769.97M
$74.41M

Cash flow (TTM)Industry

Operating Cash Flow
$131.20M
-$12.17M
Capital Expenditures
-$615.00K
-$1.03M
Free Cash Flow
$130.58M
-$20.28M
FCF Per Share
$2.02
-$0.42

Dividends and yieldsIndustry

Earnings Yield
1.03%
-22.5%
FCF Yield
1.62%
-9.38%

Taxes and interestIndustry

Income Tax
$1.43M
$80.43K
Effective Tax Rate
1.69%
20.7%

Scores and fair valueIndustry

Graham Number
$17.36
$19.07
Graham Upside
-86.1%
-47.9%
Altman Z-Score
111.24
0.22
Piotroski F-Score
5
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?